Cavalier Jason
Insider CIK 1883290 · LYRA Principal Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LYRA Lyra Therapeutics, Inc. | D To issuer | 2026-04-01 | 2026-04-03 | 667 | — | $0 | 517,880 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | S Sale | 2026-01-06 | 2026-01-08 | 769 | $3.36 | $2.6K | 518,547 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | S Sale | 2025-07-10 | 2025-07-14 | 684 | $8.91 | $6.1K | 519,316 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | A Award | 2025-01-08 | 2025-01-10 | 420,000 | — | $0 | 520,000 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | A Award | 2024-10-16 | 2024-10-18 | 100,000 | — | $0 | 100,000 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | A Award deriv | 2024-01-30 | 2024-02-01 | 200,000 | — | $0 | 200,000 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | A Award deriv | 2023-01-31 | 2023-02-02 | 140,000 | — | $0 | 140,000 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | A Award deriv | 2022-02-12 | 2022-02-15 | 15,605 | — | $0 | 15,605 | SEC↗ |
| LYRA Lyra Therapeutics, Inc. | A Award deriv | 2021-09-13 | 2021-09-15 | 104,000 | — | $0 | 104,000 | SEC↗ |